Eledon Pharmaceuticals, Inc.
ELDN
$2.62
$0.0451.75%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 107.57M | 124.88M | 140.18M | 78.19M | 83.61M |
Total Receivables | 705.00K | 761.00K | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 3.12M | 2.02M | 6.38M | 2.88M | 3.45M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 10.00K | 55.00K | 729.00K | 442.00K | 157.00K |
Total Current Assets | 111.40M | 127.72M | 143.73M | 81.51M | 87.22M |
|
|||||
Total Current Assets | 111.40M | 127.72M | 143.73M | 81.51M | 87.22M |
Net Property, Plant & Equipment | 773.00K | 850.00K | 926.00K | 471.00K | 621.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 32.39M | 32.39M | 32.39M | 32.39M | 32.39M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 346.00K | 354.00K | 363.00K | 210.00K | 255.00K |
Total Assets | 144.91M | 161.31M | 177.41M | 114.58M | 120.48M |
|
|||||
Total Accounts Payable | 5.83M | 2.90M | 5.83M | 5.86M | 2.15M |
Total Accrued Expenses | 7.55M | 5.96M | 5.43M | 6.44M | 3.61M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 336.00K | 325.00K | 314.00K | 186.00K | 269.00K |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 13.72M | 9.19M | 11.58M | 12.49M | 6.03M |
|
|||||
Total Current Liabilities | 13.72M | 9.19M | 11.58M | 12.49M | 6.03M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 467.00K | 555.00K | 640.00K | 315.00K | 386.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 24.70M | 36.99M | 47.05M | 25.71M | 122.57M |
Total Liabilities | 38.88M | 46.73M | 59.27M | 38.52M | 128.98M |
|
|||||
Common Stock & APIC | 423.68M | 476.68M | 473.70M | 386.93M | 379.44M |
Retained Earnings | -373.30M | -362.08M | -355.59M | -310.97M | -387.94M |
Treasury Stock & Other | -48.00K | -18.00K | 26.00K | 102.00K | -- |
Total Common Equity | 50.33M | 114.58M | 118.14M | 76.06M | -8.50M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 55.69M | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 55.69M | -- | -- | -- | -- |
|
|||||
Total Common Equity | 50.33M | 114.58M | 118.14M | 76.06M | -8.50M |
Total Preferred Equity | 55.69M | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 106.03M | 114.58M | 118.14M | 76.06M | -8.50M |
|